The role of the Alzheimer related Amyloid Precursor Protein Gene Family in the Developing and Adult Nervous System
The role of the Alzheimer related Amyloid Precursor Protein Gene Family in the Developing and Adult Nervous System
批准号:
30636411
负责人:
Professorin Dr. Ulrike Müller
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2006
资助国家:
德国
项目状态:
已结题
起止时间:
2005-12-31 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The role of APP as the precursor protein of the ß-amyloid peptide, which accumulates in extracellular plaques in Alzheimer¿s disease (AD), is well established and the secretases processing APP constitute major therapeutic targets. By contrast, its physiological function and the question of whether a loss of these functions contributes to pathogenesis remains largely unresolved. APP is a member of a larger gene family including the closely related APP-like proteins APLP1 and APLP2. To address the physiological functions of the APP gene family directly, we had previously generated APLP2-/-/APLP1-/-- and APLP2-/-/APP-/-- mice that die perinatally, while APLP1-/-/APP-/--mice and single mutants were viable. Recently, we generated triple mutant mice lacking all three APP/APLP family members which also died shortly after birth. Whereas lethal double mutants showed no apparent morphological abnormalities, the brains of triple mutants displayed a phenotype resembling human type II lissencephaly with ectopic clusters of neuroblasts that had migrated through the basal lamina and pial membrane, indicating a role of APP/APLPs in neruonal adhesion and/or migration. Collectively, our data demonstrate that APP/APLPs are essential for normal brain development and early postnatal survival. However, this perinatal lethality, precludes the analysis of proposed functions in the postnatal and adult, aging nervous system. Moreover, the underlying mechanism of lethality is presently unknown. The aim of the current project is thus to circumvent early lethality by two complementary approaches. To this end, we intend to (A) generate conditional null mutants using a tetracycline regulated genetic switch (tet-off) to downregulate APP/APLP expression postnatally. Secondly (B), we intend to ablate APP expression in a neuron-specific manner, either already during development in neural progenitor cells, or in postmitotic neurons postnatally. This approach will unravel whether lethality is, as hypothesized, due to compromised functions within the nervous system or due to unrelated defects in peripheral organs. We intend to characterize these mutant lines of mice with regard to the morphological and functional maturation of the nervous system, in particular synaptogenesis, neuronal plasticity, sensorimotor development, as well as learning and memory. Understanding the physiological functions of APP and its homologous in the adult and aging nervous system will be essential to unravel the misregulation and pathogenic mechanisms that lead to Alzheimer¿s disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic potential of secreted APPsalpha for Tau associated synaptic dysfunction and pathology
-
批准号:342000669
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professorin Dr. Ulrike Müller
-
依托单位:
Central Project
-
批准号:251220511
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professorin Dr. Ulrike Müller
-
依托单位:
The role of the amyloid precursor protein gene family in the adult mouse CNS
-
批准号:173181422
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professorin Dr. Ulrike Müller
-
依托单位:
Central Project
-
批准号:173248675
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professorin Dr. Ulrike Müller
-
依托单位:
A reverse genetic approach to define physiologically important functional domains of APP family proteins: analysis in APP/APLP knockout mice
-
批准号:5247598
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professorin Dr. Ulrike Müller
-
依托单位:
国内基金
海外基金
登录
查看更多内容
年轻血清介导血管内皮细胞Cdk5负调控高反应性中性粒细胞浸润入脑减轻Alzheimer’s病的机制研究
-
批准号:82271473
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:祁方昉
-
依托单位:
雌激素GPR30受体通过调节神经免疫治疗Alzheimer's病的机制研究
-
批准号:32241007
-
项目类别:专项项目
-
资助金额:63.00万元
-
批准年份:2022
-
负责人:招明高
-
依托单位:
基于AKT/mTOR/HIF-1a信号轴调控糖代谢重编程探讨补阳还五汤减轻炎症防治Alzheimer病的机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:杨琳
-
依托单位:
流感疫苗联合PD-1抗体在Alzheimer’s病治疗中的作用及机制研究
-
批准号:81971021
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:祁方昉
-
依托单位:
多功能纳米探针的构建及其在Alzheimer 病细胞多模态成像的应用研究
-
批准号:2019JJ40399
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:丁萍
-
依托单位:
Aß3-10-KLH疫苗免疫防治Alzheimer病(AD)的机制探讨
-
批准号:81870819
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2018
-
负责人:曹云鹏
-
依托单位:
α7 nAChR调控线粒体自噬在Alzheimer病发病机制中的作用研究
-
批准号:81860207
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2018
-
负责人:齐晓岚
-
依托单位:
F-18 标记β分泌酶1抑制剂用于Alzheimer 症早期诊断的基础研究
-
批准号:81771886
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:李云春
-
依托单位:
流感疫苗调控Arginase1表达在减弱Alzheimer’s病理中的作用及机制研究
-
批准号:31700914
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2017
-
负责人:祁方昉
-
依托单位:
Exendin-4通过Wnt通路减轻2型糖尿病大脑Alzheimer病样改变的机制
-
批准号:81770817
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:袁刚
-
依托单位: